Dihydropyrrolones derivative as Caspase-3 inhibitor
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of dihydropyrrolidone and its derivatives, which can be used in anti-inflammatory agents, antiviral agents, drug combinations, etc., and can solve problems such as cytotoxicity
Inactive Publication Date: 2013-08-14
SOUTH CHINA UNIV OF TECH +1
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, due to the problems of cytotoxicity and certain differences between the experimental results in vivo and in vitro, so far only a few Caspase-3 inhibitors are undergoing preclinical trial experiments, such as Merck's M-791
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0050] For the synthesis method in Example 1, refer to Method B reported in the literature (J.Comb.Chem.2009,11,685-696): primary aromatic amine (4mmol), 38% formaldehyde (120mg, 1.5mmol) and acetic acid ( 120mg, 2mmol) were sequentially added to the reaction solution (reaction 10-30 minutes) of the primary amine arylamine (1mmol) and butyndioic acid diester (1mmol) with ethanol (4mL) as the solvent, and stirred at 70°C until the reaction was complete (Reaction monitored by TLC). Use 20×20 GF 254 A thin-layer chromatography plate uses a mixed solvent of petroleum ether: ethyl acetate = 10:1-1:1 as a developing solvent, and uses ethyl acetate as an eluent to separate and purify the product.
[0051] For the synthesis method in Examples 2-15, refer to Method A reported in the literature (J.Comb.Chem.2009, 11, 685-696): primary amine (2mmol), 38% formaldehyde (120mg, 1.5mmol) and acetic acid (120mg, 2mmol) was added successively to the reaction solution (reaction of 10-30 minut...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Caspase-3 inhibitor, namely a dihydropyrrolones derivative, with a molecular structural formula (1), and pharmaceutically acceptable salts thereof. In the molecular structural formula, R1 represents alkyl, aryl or heterocyclic radical; R2 represents hydrogen, alkyl, aryl or heterocyclic radical; R3 represents alkoxyl, aryloxy, primary amino radical or secondary amino radical; and R4 represents primary amino radical, secondary amino radical, alkoxyl, aryloxy, alkylthio radical, arylthio radical or N-containing heterocyclic radical. The dihydropyrrolones derivative or the pharmaceutically acceptable salts thereof, as a Caspase-3 inhibitor, can be applied to treating diseases caused by excessive apoptosis of cells, such as acquired immunity deficiency syndrome, serious hepatitis, osteoarthritis, senile dementia, Parkinson's disease, amyotrophic lateral sclerosis, Huntingdon's chorea, spinal and cerebellar ataxia, muscular dystrophy, cerebral ischemia, cerebral injury and the like, singly or by combining with other medicines.
Description
technical field [0001] The present invention relates to dihydropyrrolidone derivatives and pharmaceutically acceptable salts thereof, and also relates to the application of dihydropyrrolone derivatives and pharmaceutically acceptable salts thereof in medicine. Background technique [0002] Apoptosis, also known as programmed cell death, is an extremely important physiological process that maintains the normal growth and development and dynamic balance of organisms together with cell proliferation. When apoptosis is insufficient, cancer, viral diseases and autoimmune diseases are prone to occur; while excessive apoptosis may cause acquired immunodeficiency syndrome, severe hepatitis, osteoarthritis and neurodegenerative diseases. The mechanism of regulating apoptosis involves a complex protease cascade reaction process, which includes a variety of regulatory factors, a class of proteases called Caspase (cysteinyl aspartate-specific protease, caspase) in the initiation and exe...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more